Clinical trials
Not yet recruiting Phase 3 Prostatic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 1 |
| 2025 | 2 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Charles LeMoyne Hospital | 1 |
| Dr. Tamim Niazi | 1 |
| Ente Ospedaliero Cantonale, Bellinzona | 1 |
| General University Hospital, Prague | 1 |
| Gustave Roussy, Cancer Campus, Grand Paris | 1 |
| Norroy Bioscience Co., LTD | 1 |
| Qilu Pharmaceutical Co., Ltd. | 1 |
| Robert Förster | 1 |
| Thomas Jefferson University | 1 |
| University of Ilorin Teaching Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 11 |
| Adenocarcinoma | 2 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.